Wollenhaupt J, Silverfield J, Bong Lee E, et al. Tofacitinib, an Oral Janus Kinase Inhibitor, in the Treatment of Rheumatoid Arthritis: Safety and Efficacy in Open-Label, Long-Term Extension Studies over 9 Years. ACR 2017, abstract 522.
Associatie tussen granuloma annulare, diabetes, hyperlipidemie en auto-immuunziekten
okt 2021 | Diabetes, RA, SLE